ESAB Corp SEC Filings

ESAB Corp director Rhonda L. Jordan reported awards of equity-based incentives. She received 813 deferred stock units, each tied to one share of ESAB common stock. These units vest in a single installment on June 1, 2027 and will be settled in stock after her separation from the company.

Jordan was also granted 2,647 stock options with an exercise price of $100.94 per share. According to the disclosure, these options vested and became exercisable on the grant date of May 8, 2026 and will expire on May 7, 2033 if not exercised.

ESAB Corp director Mitchell P. Rales reported new equity awards and updated his holdings. On May 8, 2026, he received 813 shares of common stock as an annual equity grant in the form of restricted stock units that vest on June 1, 2027. He also received a stock option for 2,647 shares at an exercise price of $100.94 per share, which is fully vested and exercisable and expires on May 7, 2033. Following these awards, he directly holds 15,836 common shares, with additional indirect holdings through the Mitchell P. Rales Family Trust, a single-member LLC owned by a revocable trust for his benefit, and custodial accounts for his daughter, for which he disclaims beneficial ownership.

ESAB Corp reported that EVP and Chief Financial Officer R. Brent Jones received new equity awards. On May 7, 2026, he was granted 14,210 employee stock options to buy common stock at an exercise price of $102.3900 per share, expiring on May 6, 2033. These options vest in three equal annual installments starting on the first day of the month following each of the first three anniversaries of the grant date.

On the same date, Jones was also granted 33,978 restricted stock units, each representing a contingent right to receive one share of ESAB common stock. These RSUs vest in three equal annual installments on the same schedule, aligning his compensation with the company’s future share performance.

ESAB Corp executive R. Brent Jones, EVP and Chief Financial Officer, has filed an initial Form 3, which reports his status as an officer and subject to insider reporting rules. The filing, as presented here, does not show any share holdings or recent transactions.

ESAB Corporation’s first quarter of 2026 showed higher sales but weaker earnings as the company prepared for a major acquisition. Net sales rose to $745.6 million from $678.1 million, driven by acquisitions and currency tailwinds, while organic volume declined due to tariffs and logistics disruptions.

Net income from continuing operations fell to $51.8 million and diluted EPS from continuing operations held at $0.82, with total diluted EPS at $0.78 versus $1.10 a year earlier. Higher restructuring, acquisition-related costs and interest expense compressed margins, even as Adjusted EBITDA edged up to $136.6 million.

ESAB agreed to acquire Eddyfi Technologies for about $1.45 billion, funding it with new $1.0 billion 2031 senior notes and roughly $318 million of equity, including 6.50% Series A Mandatory Convertible Preferred Stock. Total debt increased to $2.06 billion and cash to $1.00 billion, leaving the company more leveraged ahead of closing.

ESAB Corporation reported record first quarter 2026 results, with mixed GAAP and adjusted performance. Net sales reached $746 million, up 10% year over year, while core organic sales declined 1% excluding acquisitions and currency.

Net income from continuing operations attributable to ESAB was $50 million, or $0.82 diluted EPS, and net income attributable to ESAB was $47.6 million, or $0.78 diluted EPS, both below the prior year. Core adjusted net income rose to $80.4 million, or $1.31 diluted EPS, compared with $1.25 a year earlier. Core adjusted EBITDA increased to $135.9 million, with a 19.0% margin, 80 basis points lower than last year, reflecting acquisition dilution and costs related to the conflict in Iran.

Management highlighted strong contributions from the EWM and Aktiv acquisitions and confirmed the Eddyfi acquisition is financed and expected to close mid‑year. ESAB reiterated its full‑year 2026 outlook, targeting total core net sales growth of 6.0% to 9.0%, core adjusted EBITDA of $575 million to $595 million, and core adjusted EPS of $5.70 to $5.90, excluding any impact from Eddyfi.

ESAB Corp Schedule 13G: T. Rowe Price Associates, Inc. reports beneficial ownership of 6,664,594 shares of Common Stock, representing 10.9% of the class. The filing shows sole voting power over 6,507,328 shares and sole dispositive power over 6,664,594 shares. The form is signed by Ellen York, Vice President, dated 04/08/2026.

Han Julie reported acquisition or exercise transactions in this Form 4 filing.

ESAB Corp reported that Controller and Principal Accounting Officer Julie Han received a grant of 1,003 restricted stock units on April 1, 2026. Each unit represents a contingent right to receive one share of ESAB common stock. The units vest in three equal annual installments on the first, second and third anniversaries of the grant date. Following this compensation-related award, Han holds 1,003 restricted stock units directly.

ESAB Corp officer Julie Han, Controller and Principal Accounting Officer, filed an initial ownership report showing her equity position in the company. She directly holds 497 shares of common stock.

She also holds several grants of restricted stock units (RSUs), each representing a contingent right to receive one ESAB common share. These include RSUs tied to 387, 258, 581 and 196 underlying common shares, with vesting schedules running in annual installments through March 1, 2028 and 2030 as described in the grants’ terms.